Tyrosine kinase inhibitor effects on avian osteoclastic acid transport

J P Williams1, S E Jordan, S Barnes

  • 1Department of Pathology, University of Alabama at Birmingham, and Veteran's Affairs Medical Center, 35294-0007, USA.

Insights

Tyrosine kinase inhibitors directly block hydrochloric acid transport in osteoclast membranes, impacting bone resorption. This study explores the effects of various inhibitors on this crucial cellular process.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Tyrosine kinase pp60(c-src) is found in osteoclast membranes, suggesting a role in acid transport.
  • Osteoclasts are crucial for bone remodeling and rely on acid secretion for bone resorption.

Purpose of the Study:

  • To investigate the role of tyrosine kinase in regulating hydrochloric acid transport in osteoclasts.
  • To evaluate the efficacy of different tyrosine kinase inhibitors on osteoclast membrane acid transport and bone resorption.

Main Methods:

  • Isolated avian osteoclast membranes were used to assay acid transport via acridine orange fluorescence.
  • Tyrosine kinase inhibitors (isoflavone, tyrphostin, benzoquinonoid) and inactive analogues were tested.
  • In vitro bone resorption assays were conducted over 3-5 days to assess inhibitor effects on bone degradation.

Main Results:

  • Genistein and herbimycin inhibited hydrochloric acid transport in a dose-dependent manner, with rapid and reversible effects.
  • Herbimycin also affected chloride transport, suggesting interaction with ion channels.
  • Osteoclastic bone resorption was more sensitive to herbimycin and genistein than membrane acid transport, with tyrphostins showing limited effects on resorption.

Conclusions:

  • Tyrosine kinase inhibition directly impairs osteoclast membrane hydrochloric acid transport.
  • The varying effects of inhibitors may be attributed to their chemical properties, such as reactivity and cell permeability.
  • Targeting tyrosine kinases offers a potential strategy for modulating osteoclast activity and bone resorption.